BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15653023)

  • 21. Association of platelet responsiveness with clopidogrel metabolism: role of compliance in the assessment of "resistance".
    Serebruany V; Cherala G; Williams C; Surigin S; Booze C; Kuliczkowski W; Atar D
    Am Heart J; 2009 Dec; 158(6):925-32. PubMed ID: 19958858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting.
    Gurbel PA; Bliden KP; Hayes KM; Yoho JA; Herzog WR; Tantry US
    J Am Coll Cardiol; 2005 May; 45(9):1392-6. PubMed ID: 15862408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Not all statins interfere with clopidogrel during antiplatelet therapy.
    Mach F; Senouf D; Fontana P; Boehlen F; Reber G; Daali Y; de Moerloose P; Sigwart U
    Eur J Clin Invest; 2005 Aug; 35(8):476-81. PubMed ID: 16101667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation.
    Geisler T; Langer H; Wydymus M; Göhring K; Zürn C; Bigalke B; Stellos K; May AE; Gawaz M
    Eur Heart J; 2006 Oct; 27(20):2420-5. PubMed ID: 17005534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome.
    Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Lambert M; Camoin L; Vague IJ; Bonnet JL; Alessi MC
    Thromb Res; 2007; 120(6):893-9. PubMed ID: 17337040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.
    Ben-Dor I; Kleiman NS; Lev E
    Am J Cardiol; 2009 Jul; 104(2):227-33. PubMed ID: 19576352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes.
    Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Mielot C; Bali L; Lambert M; Alessi MC; Bonnet JL
    Thromb Haemost; 2007 Feb; 97(2):282-7. PubMed ID: 17264958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment.
    Angiolillo DJ; Costa MA; Shoemaker SB; Desai B; Bernardo E; Suzuki Y; Charlton RK; Zenni MM; Guzman LA; Bass TA
    Am J Cardiol; 2008 Feb; 101(4):440-5. PubMed ID: 18312754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inter-individual variability in response to clopidogrel in patients with coronary artery disease.
    Dziewierz A; Dudek D; Heba G; Rakowski T; Mielecki W; Dubiel JS
    Kardiol Pol; 2005 Feb; 62(2):108-17; discussion 118. PubMed ID: 15815794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy.
    Bal Dit Sollier C; Berge N; Boval B; Hovsepian L; Drouet L
    Thromb Haemost; 2009 Jan; 101(1):116-22. PubMed ID: 19132197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
    Pinto Slottow TL; Bonello L; Gavini R; Beauzile P; Sushinsky SJ; Scheinowitz M; Kaneshige K; Xue Z; Torguson R; Tantry U; Pichard AD; Satler LF; Suddath WO; Kent K; Gurbel P; Waksman R
    Am J Cardiol; 2009 Aug; 104(4):525-30. PubMed ID: 19660606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
    Patti G; Nusca A; Mangiacapra F; Gatto L; D'Ambrosio A; Di Sciascio G
    J Am Coll Cardiol; 2008 Sep; 52(14):1128-33. PubMed ID: 18804738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of cigarette smoking with enhanced platelet inhibition by clopidogrel.
    Bliden KP; Dichiara J; Lawal L; Singla A; Antonino MJ; Baker BA; Bailey WL; Tantry US; Gurbel PA
    J Am Coll Cardiol; 2008 Aug; 52(7):531-3. PubMed ID: 18687246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
    Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D
    J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S; Roe MT
    Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
    Thromb Res; 2005; 116(6):491-7. PubMed ID: 16181985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease.
    Lev EI; Arikan ME; Vaduganathan M; Alviar CL; Tellez A; Mathuria N; Builes A; Granada JF; del Conde I; Kleiman NS
    Am Heart J; 2007 Oct; 154(4):694.e1-7. PubMed ID: 17892993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention.
    Hochholzer W; Trenk D; Frundi D; Blanke P; Fischer B; Andris K; Bestehorn HP; Büttner HJ; Neumann FJ
    Circulation; 2005 May; 111(20):2560-4. PubMed ID: 15809367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.